CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
biopsy alone in diagnosing subjects with clinically significant prostate cancer with MRI visible lesions. This study will consist o...
New York, New York, United States and 2 other locations
plus valacyclovir in men with localized, intermediate-risk prostate cancer who are planning to receive external beam radiation ther...
Phase 2
Saddle Brook, New Jersey, United States and 6 other locations
and docetaxel in patients with newly metastatic, hormone-sensitive prostate cancer (mHSPC), using a primary endpoint of undetectabl...
Phase 2
New York, New York, United States
of this study is to evaluate the safety, tolerability, and antitumour activity of AZD0754 CAR T-cell therapy in participants with metastatic prostate...
Phase 1, Phase 2
New York, New York, United States and 14 other locations
Darolutamide and Pembrolizumab in a stratified high-risk localized prostate cancer cohort, followed by adjuvant treatment with Pemb...
Phase 2
New York, New York, United States
the UroNav software and DynaCAD software for planning and treating prostate cancer as an add on to the already approved workflow of...
New York, New York, United States and 2 other locations
This is a phase 1 study to assess the safety and tolerability of ARX517 as monotherapy or combination therapy in adult subjects with metastatic prostate...
Phase 1
New York, New York, United States and 11 other locations
in men with biopsy-proven, low-risk or favorable intermediate-risk prostate cancer managed with active surveillance. The study aims...
Phase 2
New York, New York, United States
approach of radiation therapy for people with intermediate-risk prostate cancer receiving standard stereotactic body radiotherapy (...
Phase 3
New York, New York, United States and 7 other locations
the SpaceOAR Vue System in reducing late gastrointestinal (GI) toxicity in subjects undergoing Stereotactic Body Radiotherapy (SBRT) to treat prostate...
Bloomfield, New Jersey, United States and 29 other locations
Clinical trials
Research sites
Resources
Legal